Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

Ann: 2019 Letter to Shareholders, page-22

First 22 Last

Share
Profile

Follow
AlCp

26,845 Posts.

1738

25/11/19

13:09

Post #: 41614366
Share

Originally posted by C'mon go up! ↑

One thing that was new for me (Not sure if others knew already) was this lil statement.

"We are excited to be collaborating with Sanofi’s Consumer Health team to design and build a smartphone application that would allow consumers to self-assess their respiratory symptoms, and most importantly, provide next steps. This is a challenging task but with the combined strengths of the teams involved we are already making significant progress."

I was always under the impression the app was only for clinics to use. This now branches it to home use which is what I was always hoping for and makes in my opinion the best use case for this tech - Self diagnosis to trigger a visit to the doc.

Expand

I think it will be an extension to ResAppDx, likely a screening and management tool for asthma.

Last edited by AlCp: 25/11/19

RAP Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Talking Australia's very competitive property landscape: Realty Talks

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 76 more messages in this thread...

First 22 Last

Add RAP (ASX) to my watchlist